VIRGIN GALACTIC HOLDINGS INC (SPCE)

US92766K1060 - Common Stock

0.97  +0.03 (+2.9%)

After market: 0.9701 +0 (+0.01%)

Fundamental Rating

3

Taking everything into account, SPCE scores 3 out of 10 in our fundamental rating. SPCE was compared to 64 industry peers in the Aerospace & Defense industry. While SPCE seems to be doing ok healthwise, there are quite some concerns on its profitability. SPCE shows excellent growth, but is valued quite expensive already.



0

1. Profitability

1.1 Basic Checks

SPCE had negative earnings in the past year.
In the past year SPCE has reported a negative cash flow from operations.
SPCE had negative earnings in each of the past 5 years.
SPCE had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

SPCE's Return On Assets of -42.59% is on the low side compared to the rest of the industry. SPCE is outperformed by 75.00% of its industry peers.
SPCE's Return On Equity of -99.38% is on the low side compared to the rest of the industry. SPCE is outperformed by 70.31% of its industry peers.
Industry RankSector Rank
ROA -42.59%
ROE -99.38%
ROIC N/A
ROA(3y)-39.83%
ROA(5y)-47.04%
ROE(3y)-81%
ROE(5y)-85.6%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SPCE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

SPCE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SPCE has more shares outstanding
SPCE has more shares outstanding than it did 5 years ago.
SPCE has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -2.88, we must say that SPCE is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -2.88, SPCE is doing worse than 76.56% of the companies in the same industry.
A Debt/Equity ratio of 0.83 indicates that SPCE is somewhat dependend on debt financing.
SPCE has a Debt to Equity ratio of 0.83. This is in the lower half of the industry: SPCE underperforms 70.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF N/A
Altman-Z -2.88
ROIC/WACCN/A
WACC8.02%

2.3 Liquidity

SPCE has a Current Ratio of 5.12. This indicates that SPCE is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of SPCE (5.12) is better than 96.88% of its industry peers.
SPCE has a Quick Ratio of 5.03. This indicates that SPCE is financially healthy and has no problem in meeting its short term obligations.
SPCE has a better Quick ratio (5.03) than 98.44% of its industry peers.
Industry RankSector Rank
Current Ratio 5.12
Quick Ratio 5.03

7

3. Growth

3.1 Past

SPCE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.93%, which is quite good.
SPCE shows a strong growth in Revenue. In the last year, the Revenue has grown by 193.06%.
SPCE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 204.86% yearly.
EPS 1Y (TTM)16.93%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q52.73%
Revenue 1Y (TTM)193.06%
Revenue growth 3Y204.86%
Revenue growth 5YN/A
Revenue growth Q2Q222.87%

3.2 Future

The Earnings Per Share is expected to grow by 20.05% on average over the next years. This is a very strong growth
Based on estimates for the next years, SPCE will show a very strong growth in Revenue. The Revenue will grow by 184.90% on average per year.
EPS Next Y36.09%
EPS Next 2Y23.29%
EPS Next 3Y19.56%
EPS Next 5Y20.05%
Revenue Next Year-25.03%
Revenue Next 2Y-31.13%
Revenue Next 3Y158.61%
Revenue Next 5Y184.9%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SPCE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SPCE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

SPCE's earnings are expected to grow with 19.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.29%
EPS Next 3Y19.56%

0

5. Dividend

5.1 Amount

SPCE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

VIRGIN GALACTIC HOLDINGS INC

NYSE:SPCE (4/18/2024, 7:21:06 PM)

After market: 0.9701 +0 (+0.01%)

0.97

+0.03 (+2.9%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap388.04M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -42.59%
ROE -99.38%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 5.12
Quick Ratio 5.03
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)16.93%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y36.09%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)193.06%
Revenue growth 3Y204.86%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y